MYD88 and Waldenstrom macroglobulinemia: Although molecular testing for the MYD88 L265P mutation - strongly associated with Waldenström’s macroglobulinemia - was not available in our setting, its detection could further refine the diagnosis and guide the use of targeted therapies [10].